The efficacy and safety of Apatinib in the treatment of advanced non-small cell lung cancer: A retrospective trial

BACKGROUND: As a potent inhibitor of the vascular endothelial growth factor (VEGF) signaling pathway, Apatinib has been used in antitumor treatment for some time. The study aimed to research the therapeutic effects and toxicity of Apatinib in the treatment of advanced non-small cell lung cancer (NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jijin, Huang, Di, Yang, Wenjing, Song, Qingxu, Jia, Yibin, Chen, Pengxiang, Cheng, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727187/
https://www.ncbi.nlm.nih.gov/pubmed/36505785
http://dx.doi.org/10.3389/fonc.2022.1030798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727187/
https://www.ncbi.nlm.nih.gov/pubmed/36505785
http://dx.doi.org/10.3389/fonc.2022.1030798

Ejemplares similares